about
Echo and BNP serial assessment in ambulatory heart failure care: Data on loop diuretic use and renal function.The left ventricle as a mechanical engine: from Leonardo da Vinci to the echocardiographic assessment of peak power output-to-left ventricular mass.Management of heart failure in the new era: the role of scores.Effects of acute myocardial ischemia on QT dispersion by dipyridamole stress echocardiography.Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling.Combining echo and natriuretic peptides to guide heart failure care in the outpatient setting: A position paper.Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: An observational study of 1137 outpatients.Prognostic Value of Right Ventricular Dysfunction in Heart Failure With Reduced Ejection Fraction: Superiority of Longitudinal Strain Over Tricuspid Annular Plane Systolic Excursion.Reproducibility of echocardiographic assessment of 2D-derived longitudinal strain parameters in a population-based study (the STANISLAS Cohort study).Fibrosis assessment by integrated backscatter and its relationship with longitudinal deformation and diastolic function in heart failure with preserved ejection fraction.Unraveling the relationship between serum uric acid levels and cardiovascular risk.Risk stratification of Asian patients with heart failure and reduced ejection fraction: the effectiveness of the Echo Heart Failure Score.Non-cardiac factors for prediction of response to cardiac resynchronization therapy: The value of baseline, and of serial changes, in red cell distribution width.Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction.Improvement of myocardial performance (Tei) index closely reflects intrinsic improvement of cardiac function: assessment in revascularized hibernating myocardium.Improved cardiovascular risk stratification by a simple ECG index in hypertension.Machine Learning Analysis of Left Ventricular Function to Characterize Heart Failure With Preserved Ejection Fraction.Right ventricular recovery during follow-up is associated with improved survival in patients with chronic heart failure with reduced ejection fraction.Elevated serum uric acid concentration at discharge confers additive prognostic value in elderly patients with acute heart failureThe ‘Echo Heart Failure Score’: an echocardiographic risk prediction score of mortality in systolic heart failureLeft Atrial Reservoir Function and Outcome in Heart Failure With Reduced Ejection FractionPrognostic Value of Right Ventricular Dysfunction on Clinical Outcomes After Transcatheter Aortic Valve ReplacementAdvantages of deformation indices over systolic velocities in assessment of longitudinal systolic function in patients with heart failure and normal ejection fractionPresence of Extensive LV Remodeling Limits the Benefits of CRT in Patients With Intraventricular DyssynchronyLow-dose dipyridamole infusion acutely increases exercise capacity in angina pectorisPrognostic value of left ventricular hypertrophy and geometry in patients with a first, uncomplicated myocardial infarctionUsefulness of the severity and extent of wall motion abnormalities as prognostic markers of an adverse outcome after a first myocardial infarction treated with thrombolytic therapyC-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarctionExercise elicits dynamic changes in extravascular lung water and haemodynamic congestion in heart failure patients with preserved ejection fraction[Hypokinetic cardiac arrest and hypereosinophilia: a case of Kounis or Churg-Strauss syndrome?]
P50
Q36214002-5627BE53-426A-4233-83D9-E48E1FF05A2AQ37936162-109C0FF6-3093-4D5B-A3FF-B6E261110572Q38235976-4280C79A-3521-4299-A64B-85AE450D7236Q39397897-DB33BF8A-7649-47A7-A2C1-8261A2FFE179Q46974553-C498D6E1-36EF-43E5-88FE-93A7D8655AD3Q48170133-6371A92E-6A58-4E76-A3E7-9C6F9CB51783Q48464283-D62EE4F6-B5EF-4320-824E-ED402B56165AQ48508223-FD52EE02-4D98-4964-BBDD-F42147766958Q48563169-F7BD08A9-59CE-4A00-922F-44FB01F30609Q48619525-F05467FF-6314-4BDA-8664-77FA534C045CQ50148970-C2979ED6-CEF1-4BD5-B9D7-B94FD0ABF6B1Q50201102-ED6C07F5-4C9F-4671-8905-BA9F25FA5F97Q50205304-48A198B0-65CB-4ABA-9374-7D0D8FBF1E80Q51061452-34AEDC00-A737-45BE-BA8D-BD332435BE6BQ51489146-BA168D41-640C-4F35-865F-2B0C386BBD60Q52012107-7864EDC3-C0FB-4971-B37B-84C1C9FE3F0AQ52584778-0CD58134-3B29-4369-81F5-7FC51FABB174Q54404147-5F8DD251-847E-454B-AFA2-0A9B5D71BD9CQ56394663-76AB7044-670E-4901-8B44-2E33E6FE5ABEQ57551507-B444E6EF-D1F1-4437-810E-5310DA2CB48FQ62818217-BAB5BB29-A9FB-4887-96E3-8045846D12B1Q62818229-3AC618E8-5D06-4BEA-809F-292A9248ABF4Q62818387-52D093F1-0A43-4712-AF26-2DE161EA15A0Q62818405-50389534-437F-40EA-AE12-D9DE4082A667Q62818449-63F60A62-8DC5-45A8-B320-713744EDF096Q62818473-6E08379C-DA27-4AD8-A692-0D19AD12CB84Q62818491-EC185D8B-A80F-4EFC-96D1-48F9E99F811DQ62818504-904FCB24-CB0E-4E6C-BAA8-33B949385C96Q89254960-022A68CA-2516-439B-9AE0-4FA09E86E7DEQ93053741-CA08C0E1-4A91-46A4-B650-FFBE5283EA3D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Erberto Carluccio
@ast
Erberto Carluccio
@en
Erberto Carluccio
@es
Erberto Carluccio
@nl
Erberto Carluccio
@sl
type
label
Erberto Carluccio
@ast
Erberto Carluccio
@en
Erberto Carluccio
@es
Erberto Carluccio
@nl
Erberto Carluccio
@sl
prefLabel
Erberto Carluccio
@ast
Erberto Carluccio
@en
Erberto Carluccio
@es
Erberto Carluccio
@nl
Erberto Carluccio
@sl
P106
P1153
6602362138
P21
P31
P496
0000-0002-9296-4397